AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CLINUVEL PHARMACEUTICALS LTD

11.670

-0.040-0.34%

Volume:69.13K

Turnover:804.90K

Market Cap:585.84M

PE:16.25

High:11.870

Open:11.690

Low:11.310

Close:11.710

52wk High:13.933

52wk Low:9.365

Shares:50.20M

Float Shares:41.32M

Volume Ratio:0.50

T/O Rate:0.17%

Dividend:0.05

Dividend Rate:0.43%

EPS(TTM):0.718

EPS(LYR):0.718

ROE:16.30%

ROA:11.37%

PB:2.43

PE(LYR):16.25

Loading ...

Overview Company News Filings

Company Profile

Company Name:

CLINUVEL PHARMACEUTICALS LTD

Exchange:

ASX

Establishment Date:

1999

Employees:

16

Office Location:

535 Bourke Street,Level 22,Melbourne,Victoria,Australia

Website:

http://www.clinuvel.com

Zip Code:

3000

Phone:

Fax:

61 3 9660 4909

Introduction:

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing drugs for the treatment of severe genetic and skin disorders in Europe, the United States, and Singapore. Its lead drug candidate is SCENESSE, a photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria. The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; and VLRX001, an addition to the family of melanocortin analogues, which provoke increased and prolonged cellular activity. Clinuvel Pharmaceuticals Limited has a collaboration agreement with HK Winhealth Pharma Group Co. Limited for launching SCENESSE under a named patient program for the treatment of patients with erythropoietic protoporphyria in the People's Republic of China. The company was incorporated in 1999 and is headquartered in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CUV.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CUV.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","market":"AU","secType":"STK","nameCN":"CLINUVEL PHARMACEUTICALS LTD","latestPrice":11.67,"timestamp":1771564320000,"preClose":11.71,"halted":0,"volume":69127,"delay":0,"changeRate":-0.00341588385994884,"nameEN":"CLINUVEL PHARMACEUTICALS LTD","floatShares":41318955,"shares":50200740,"eps":0.717999,"marketStatus":"Market Closed","change":-0.04,"latestTime":"02-20 16:12:00 AEDT","open":11.69,"high":11.87,"low":11.31,"amount":804900,"amplitude":0.047822,"askPrice":11.68,"askSize":40,"bidPrice":11.6,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.717999,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1771801200000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":11.71,"dividendRate":0.004284,"openAndCloseTimeList":[[1771542000000,1771563600000]],"volumeRatio":0.4960439616098177,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CUV.AU\",,,,,undefined,":{"symbol":"CUV.AU","floatShares":41318955,"roa":"11.37%","roe":"16.30%","lyrEps":0.717999,"volumeRatio":0.4960439616098177,"shares":50200740,"dividePrice":0.05,"high":11.87,"amplitude":0.047822,"preClose":11.71,"low":11.31,"week52Low":9.365,"pbRate":"2.43","psRate":"6.17","week52High":13.933,"institutionHeld":0,"latestPrice":11.67,"committee":0.428571,"eps":0.717999,"divideRate":0.004284,"volume":69127,"delay":0,"ttmEps":0.717999,"open":11.69,"prevYearClose":12.46,"prevWeekClose":10.6,"prevMonthClose":11,"prevQuarterClose":12.46,"fiveDayClose":10.6,"twentyDayClose":12.1,"sixtyDayClose":11.05,"earningDate":1772035200000,"dividendPayoutRate":0.06921842705277628,"dividendFrequency":"A","dividendGrowthYears":5,"dividendGrowthRate":0,"fiveYearAvgDividendRate":0.0025824359172833843},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CUV.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-26","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1772060400000,"name":null,"time":"","dateTimestamp":1772024400000,"actualEps":null},{"date":"2025-09-04","symbol":"CUV.AU","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-05","defaultRemindTime":1756944000000,"name":"CLINUVEL PHARMACEUTICALS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-19","payableDate":"2025-09-05","currency":"AUD","dateTimestamp":1756908000000,"payDate":"2025-09-19"},{"date":"2025-08-28","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756339200000,"name":null,"time":"","dateTimestamp":1756303200000,"actualEps":null},{"date":"2025-02-26","symbol":"CUV.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1740524400000,"name":null,"time":"","dateTimestamp":1740488400000,"actualEps":null},{"date":"2024-09-05","symbol":"CUV.AU","amount":0.05,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2024-09-06","defaultRemindTime":1725494400000,"name":"CLINUVEL PHARMACEUTICALS LTD","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-09-20","payableDate":"2024-09-06","currency":"AUD","dateTimestamp":1725458400000,"payDate":"2024-09-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CUV.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-03","recordDate":"2020-09-04","paymentDate":"2020-09-18","value":0.025,"currency":"AUD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-17","value":0.025,"currency":"AUD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-09-21","value":0.04,"currency":"AUD"},{"executeDate":"2023-09-05","recordDate":"2023-09-06","paymentDate":"2023-09-20","value":0.05,"currency":"AUD"},{"executeDate":"2024-09-05","recordDate":"2024-09-06","paymentDate":"2024-09-20","value":0.05,"currency":"AUD"}],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":6117181,"yearFounded":1999,"employeeNum":16,"address":"535 Bourke Street,Level 22,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9660 4900","officeFax":"61 3 9660 4909"},"stockCompanyDetail":{"websiteUrl":"http://www.clinuvel.com","stockEarnings":[{"period":"1week","weight":0.1009},{"period":"1month","weight":-0.0283},{"period":"3month","weight":0.0856},{"period":"6month","weight":-0.0931},{"period":"1year","weight":0.0359},{"period":"ytd","weight":-0.0634}],"compareEarnings":[{"period":"1week","weight":0.0173},{"period":"1month","weight":0.0113},{"period":"3month","weight":0.0666},{"period":"6month","weight":0.055},{"period":"1year","weight":0.2181},{"period":"ytd","weight":0.0215}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing drugs for the treatment of severe genetic and skin disorders in Europe, the United States, and Singapore. Its lead drug candidate is SCENESSE, a photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria. The company's pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; and VLRX001, an addition to the family of melanocortin analogues, which provoke increased and prolonged cellular activity. Clinuvel Pharmaceuticals Limited has a collaboration agreement with HK Winhealth Pharma Group Co. Limited for launching SCENESSE under a named patient program for the treatment of patients with erythropoietic protoporphyria in the People's Republic of China. The company was incorporated in 1999 and is headquartered in Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.033629},{"month":2,"riseRate":0.56,"avgChangeRate":0.008218},{"month":3,"riseRate":0.52,"avgChangeRate":0.012936},{"month":4,"riseRate":0.52,"avgChangeRate":0.049433},{"month":5,"riseRate":0.24,"avgChangeRate":-0.052146},{"month":6,"riseRate":0.6,"avgChangeRate":0.068032},{"month":7,"riseRate":0.6,"avgChangeRate":0.058534},{"month":8,"riseRate":0.48,"avgChangeRate":-0.004565},{"month":9,"riseRate":0.52,"avgChangeRate":0.020713},{"month":10,"riseRate":0.44,"avgChangeRate":0.036647},{"month":11,"riseRate":0.52,"avgChangeRate":0.025676},{"month":12,"riseRate":0.56,"avgChangeRate":0.063246}],"exchange":"ASX","name":"CLINUVEL PHARMACEUTICALS LTD","nameEN":"CLINUVEL PHARMACEUTICALS LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CUV.AU\",market:\"AU\",,,undefined,":null}}